The proposed bill amends the Rhode Island Medicaid Reform Act of 2008 by introducing a new section, 42-12.4-10, which mandates Medicaid coverage for fertility diagnostic care, standard fertility preservation services, and fertility treatment starting January 1, 2026. The coverage will include medically necessary ovulation-enhancing drugs, at least three cycles of ovulation-enhancing medication treatment, intrauterine insemination, and, if necessary, in-vitro fertilization and embryo transfer as recommended by a physician. Additionally, the bill ensures that coverage is provided without discrimination based on various factors such as age, gender, and marital status.

Furthermore, the bill requires the department to submit a report to the General Assembly by January 1, 2026, detailing the medical necessity of in-vitro fertilization under federal law, potential methods for covering it as a medical assistance benefit, and the funding required for such coverage. Definitions for key terms related to fertility care, such as "infertility," "intrauterine insemination," and "standard fertility preservation services," are also included to clarify the scope of the coverage mandated by the bill. The act will take effect upon passage.